Author

F. Momburg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 5 Organism:human· 5 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:genetic perturbation / CRISPR· 1 Assay:imaging· 1

Frequent Co-Authors

U. Protzer· 2 shared A. B. Riemer· 1 shared A. Cid-Arregui· 1 shared A. Halenius· 1 shared A. Kayhan· 1 shared B. S. Möhl· 1 shared C. Gerke· 1 shared C. Jürges· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 9 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

U. Protzer

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

optiPRM: A targeted immunopeptidomics LC-MS workflow with ultra-high sensitivity for the detection of mutation-derived tumor neoepitopes from limited input material

M. Salek, J. D. Forster, J. P. Becker, M. Meyer, P. Charoentong, Y. Lyu, K. Lindner, C. Lotsch, M. Volkmar, F. Momburg, I. Poschke, S. Frohling, M. Schmitz, R. Offringa, M. Platten, , A. B. Riemer

The paper introduces optiPRM, a targeted LC-MS workflow that enhances sensitivity for detecting mutation-derived neoepitopes from limited tumor samples.

Molecular & Cellular Proteomics · Sep 1, 2024Peer-reviewedImmunology

Hepatitis B virus neutralization with DNA origami nanoshells

E.-M. Willner, F. Kolbe, F. Momburg, U. Protzer, H. Dietz

This study uses DNA origami nanoshells to neutralize hepatitis B virus in cell culture by trapping the virus and enhancing antibody effectiveness through multivalent binding and physical barriers.

bioRxiv · Dec 20, 2023Biophysics

Multimodal HLA-I genotype regulation by human cytomegalovirus US10 and resulting surface patterning

C. Gerke, L. Bauersfeld, V. Oberhardt, C. Jürges, R. Spaapen, C. Mussolino, V. T. K. Le-Trilling, M. Trilling, L. Dölken, F. Erhard, M. Hofmann, H. Hengel, F. Momburg, A. Halenius

This study investigates how HCMV US10 protein regulates HLA-I genotype and surface expression, revealing its multimodal effects on different HLA-I allotypes.

bioRxiv · Jan 10, 2023Microbiology

Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane

L. Zhao, F. Chen, O. Quitt, M. Festag, M. Ringelhan, K. Wisskirchen, J. Hasreiter, L. Yakovleva, C. Sureau, F. Bohne, M. Aichler, V. Bruss, M. Shevtsov, M. A. van de Klundert, F. Momburg, , U. Protzer

This study shows HBV envelope proteins are present on the host cell plasma membrane and can be targeted by T-cells for therapeutic purposes.

bioRxiv · Dec 21, 2020Microbiology

Activating NK- receptors, homing selectins and inhibitory Siglecs recognize EBOLA-GP and HPV-L1NK

M. Jarahian, K. Marstaller, H. Wurmbäck, N. Banna, R. Ahani, M. H. Etemadzadeh, L. K. Boller, A. Kayhan, A. Cid-Arregui, M. R. Berger, F. Momburg, C. Watzl

This study identifies NK receptors, selectins, and Siglecs as receptors for Ebola-GP and HPV-L1, showing their role in virus recognition and immune escape.

bioRxiv · Jul 24, 2020 · PreprintImmunology